For the quarter ended December 2024, M/A-Com (MTSI) reported revenue of $218.12 million, up 38.8% over the same period last year. EPS came in at $0.79, compared to $0.58 in the year-ago quarter. The ...
A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...